This study aims to evaluate the impact of different discontinuation intervals of GLP-1 receptor agonists prior to colonoscopy on bowel preparation quality and the need for repeat colonoscopy, in order to establish appropriate discontinuation recommendations.
Inclusion Criteria:
Inclusion Criteria for non GLP-1 user:
Exclusion Criteria:
• Presence of severe comorbid conditions that preclude the safe performance of colonoscopy (e.g., unstable angina, recent myocardial infarction, decompensated heart failure, chronic respiratory disease, or bleeding diathesis).
ioudanny520@hotmail.com+886928139643
GLP-1 stop for 1 week
GLP-1 not stop for 1 week
New Taipei, Taiwan 24352, Taiwan
danny520julia@gmail.com0928139643
The Impact of GLP Medication on Colonoscopy Bowel Preparation Quality
A Safety and Efficacy Comparison of BLI4700 Bowel Prep Versus an FDA-approved Comparator in Adults Prior to Colonoscopy
App-Based Education and Low-Residue Diet for Colonoscopy Preparation
Study of Efficacy and Tolerability of Various Bowel Preps in Diabetic Patients
Efficacy and Acceptability of Low-Residue Diet Package (Enimaclin®) as Diet Control Before Colonoscopy
BLI800-303: An Efficacy Evaluation of 2 Different Bowel Cleansing Preparations in Adult Subjects
Study 301: BLI4900 Versus an FDA-approved Comparator in Adult Subjects Prior to Colonoscopy
Study 302: BLI4900 Versus an FDA-approved Comparator in Adult Subjects Prior to Colonoscopy